- 专利标题： MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN
-
申请号： US16186879申请日： 2018-11-12
-
公开(公告)号： US20190062374A1公开(公告)日： 2019-02-28
- 发明人: Zheng Xin Dong , Daniel B. Deoliveira , Jeanne Mary Comstock
- 申请人： Ipsen Pharma S.A.S.
- 申请人地址： FR Boulogne Billancourt
- 专利权人： Ipsen Pharma S.A.S.
- 当前专利权人： Ipsen Pharma S.A.S.
- 当前专利权人地址： FR Boulogne Billancourt
- 主分类号： C07K7/06
- IPC分类号： C07K7/06 ; C07K14/68 ; C07K7/56 ; A61K38/00
摘要：
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.
信息查询
